Agilent acquires Proscia for USD240m

BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma

United Therapeutics eliminates Pfizer royalty obligations on ralinepag for USD525m

Pentixapharm advances preparationsfor Phase 3 PANDA study

StimLabs launches DermaForm collagen scaffold particulate device

Merck launches Phase 3 trial of Ohtuvayre for COPD exacerbation prevention

Vivesto secures US orphan drug designation for Cantrixil in acute myeloid leukemia

Lupin's Amifampridine Tablets approved by US FDA

Roche wins FDA clearance for customisable respiratory pathogen test

INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP

Immunome secures EMA validation of varegacestat application for desmoid tumors

FDA approves Sun Pharma's ILUMYA for psoriatic arthritis

AFT Pharmaceuticals' COMBOGESIC pain medication available to US healthcare organisations through Mark Cuban Cost Plus Marketplace

Celularity and Vesalius sign exclusive US peptide manufacturing agreement

Daiichi Sankyo secures EMA validation for two triple-combination cholesterol therapies